Unlocking the potential of microfluidics in mass spectrometry-based immunopeptidomics for tumor antigen discovery

The identification of tumor-specific antigens (TSAs) is critical for developing effective cancer immunotherapies. Mass spectrometry (MS)-based immunopeptidomics has emerged as a powerful tool for identifying TSAs as physical molecules. However, current immunopeptidomics platforms face challenges in...

Descripción completa

Detalles Bibliográficos
Autores principales: Stutzmann, Charlotte, Peng, Jiaxi, Wu, Zhaoguan, Savoie, Christopher, Sirois, Isabelle, Thibault, Pierre, Wheeler, Aaron R., Caron, Etienne
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2023
Materias:
Perspective
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326451/
https://www.ncbi.nlm.nih.gov/pubmed/37426761
http://dx.doi.org/10.1016/j.crmeth.2023.100511

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10326451/
https://www.ncbi.nlm.nih.gov/pubmed/37426761
http://dx.doi.org/10.1016/j.crmeth.2023.100511

Ejemplares similares